V. de Rosa

发表

New emerging drugs in soft tissue sarcoma.

F. Caponigro, F. Fazioli, G. Apice, 2006, Critical reviews in oncology/hematology.

Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate).

G. Botti, R. Franco, S. Lastoria, 2006, Frontiers in bioscience : a journal and virtual library.

Leiomyosarcoma of the Oropharynx and Neurogenic Tumors in a Young Patient With Turner's Syndrome

G. Botti, V. Ninfo, G. Apice, 2001, Sarcoma.

Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma

F. Russo, S. Lastoria, F. Frigeri, 2009, American journal of hematology.

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

S. Pignata, V. Zagonel, G. Scambia, 2007, British Journal of Cancer.

Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.

R. Thomas, G. Botti, G. D'aiuto, 2001, Seminars in oncology.

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).

F. Caponigro, E. Di Gennaro, A. Avallone, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

F. Caponigro, A. Avallone, G. Comella, 2002, Oncology.

Prognostic Value of CD40 in Adult Soft Tissue Sarcomas

G. Botti, P. Ascierto, F. Fazioli, 2004, Clinical Cancer Research.

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

R. Thomas, P. Vallone, G. Botti, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.

F. Chiarotti, R. Arcieri, M. Puopolo, 1995, Haematologica.

New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.

N. Normanno, F. Caponigro, M. Basile, 2005, Anti-cancer drugs.

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

F. Caponigro, R. Iaffaioli, A. Milano, 2007, Expert opinion on therapeutic targets.

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.

F. Izzo, P. Vallone, S. Curley, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.

F. Izzo, S. Curley, P. Ascierto, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.

F. Izzo, P. Ascierto, E. Simeone, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment

F. Marincola, P. Ascierto, J. Kirkwood, 2010, Journal of Translational Medicine.

Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.

F. Izzo, F. Fiore, A. Avallone, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.

F. Caponigro, J. Bryce, A. Avallone, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study

R. Thomas, G. Botti, G. D'aiuto, 2006, British Journal of Cancer.

Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients

P. Vallone, G. D'aiuto, G. Botti, 2005, Oncology.

Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients

L. Ellis, F. Izzo, P. Vallone, 2004, Annals of Surgical Oncology.

Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer

F. Izzo, F. Fiore, C. Sandomenico, 2006, Anti-cancer drugs.